Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$156.87
-0.5%
$153.75
$140.68
$169.99
$377.51B0.418.08 million shs7.87 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.65
-0.5%
$23.89
$20.92
$31.54
$145.83B0.5841.85 million shs34.84 million shs
Phillips 66 stock logo
PSX
Phillips 66
$131.66
-2.0%
$119.47
$91.01
$150.12
$53.66B1.023.12 million shs1.68 million shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.00%+0.62%+0.17%+3.46%+4.99%
Pfizer Inc. stock logo
PFE
Pfizer
0.00%+0.81%+3.22%+17.19%-9.52%
Phillips 66 stock logo
PSX
Phillips 66
0.00%+3.83%+8.36%+35.41%-1.72%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.8102 of 5 stars
2.34.04.23.93.51.71.9
Pfizer Inc. stock logo
PFE
Pfizer
4.9707 of 5 stars
3.23.04.24.52.61.73.1
Phillips 66 stock logo
PSX
Phillips 66
4.5415 of 5 stars
2.33.04.20.02.83.32.5
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.55
Moderate Buy$171.009.01% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.45
Hold$28.5511.31% Upside
Phillips 66 stock logo
PSX
Phillips 66
2.53
Moderate Buy$135.072.59% Upside

Current Analyst Ratings Breakdown

Latest JNJ, PFE, and PSX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/11/2025
Phillips 66 stock logo
PSX
Phillips 66
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingSector Outperform ➝ Sector Perform$133.00
7/10/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingUnderperform ➝ Underperform
7/10/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$169.00 ➝ $171.00
7/10/2025
Phillips 66 stock logo
PSX
Phillips 66
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$131.00 ➝ $148.00
7/9/2025
Phillips 66 stock logo
PSX
Phillips 66
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$115.00 ➝ $127.00
6/18/2025
Phillips 66 stock logo
PSX
Phillips 66
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$115.00
6/18/2025
Phillips 66 stock logo
PSX
Phillips 66
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral
6/18/2025
Phillips 66 stock logo
PSX
Phillips 66
Compass Point
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
6/18/2025
Phillips 66 stock logo
PSX
Phillips 66
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$130.00
6/11/2025
Phillips 66 stock logo
PSX
Phillips 66
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$149.00 ➝ $147.00
6/5/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00
(Data available from 7/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.25$13.12 per share11.96$29.69 per share5.28
Pfizer Inc. stock logo
PFE
Pfizer
$63.63B2.29$4.36 per share5.88$15.62 per share1.64
Phillips 66 stock logo
PSX
Phillips 66
$145.50B0.37$12.12 per share10.86$68.92 per share1.91
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$8.9917.4514.172.1424.42%33.46%13.30%7/16/2025 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$8.03B$1.3818.598.470.9312.62%20.33%8.53%8/5/2025 (Estimated)
Phillips 66 stock logo
PSX
Phillips 66
$2.12B$4.3939.9111.112.111.32%4.83%1.91%7/25/2025 (Estimated)

Latest JNJ, PFE, and PSX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/5/2025Q2 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/AN/AN/A$13.43 billionN/A
7/25/2025Q2 2025
Phillips 66 stock logo
PSX
Phillips 66
$1.79N/AN/AN/A$32.11 billionN/A
7/16/2025Q2 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.65N/AN/AN/A$22.85 billionN/A
4/29/2025Q1 2025
Pfizer Inc. stock logo
PFE
Pfizer
$0.67$0.92+$0.25$0.52$14.43 billion$13.72 billion
4/25/2025Q1 2025
Phillips 66 stock logo
PSX
Phillips 66
$0.07-$0.90-$0.97$1.18$31.93 billion$31.92 billion
4/15/2025Q1 2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59$2.77+$0.18$4.54$21.65 billion$21.89 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$5.203.31%N/A57.84%64 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.726.71%N/A124.64%16 Years
Phillips 66 stock logo
PSX
Phillips 66
$4.803.65%N/A109.34%14 Years

Latest JNJ, PFE, and PSX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/25/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.08%7/25/20257/25/20259/2/2025
7/10/2025
Phillips 66 stock logo
PSX
Phillips 66
quarterly$1.203.57%8/19/20258/19/20259/2/2025
4/23/2025
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.437.69%5/9/20255/9/20256/13/2025
4/15/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.303.37%5/27/20255/27/20256/10/2025
4/21/2025
Phillips 66 stock logo
PSX
Phillips 66
quarterly$1.204.94%5/19/20255/19/20256/2/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.49
1.26
1.03
Pfizer Inc. stock logo
PFE
Pfizer
0.64
1.26
0.96
Phillips 66 stock logo
PSX
Phillips 66
0.63
1.23
0.88

Institutional Ownership

CompanyInstitutional Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%
Phillips 66 stock logo
PSX
Phillips 66
76.93%

Insider Ownership

CompanyInsider Ownership
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%
Phillips 66 stock logo
PSX
Phillips 66
0.22%
CompanyEmployeesShares OutstandingFree FloatOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
138,1002.41 billion2.40 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
81,0005.69 billion5.68 billionOptionable
Phillips 66 stock logo
PSX
Phillips 66
13,200407.44 million406.54 millionOptionable

Recent News About These Companies

Phillips 66 (NYSE:PSX) Price Target Raised to $148.00
Country Club Bank Reduces Stake in Phillips 66 (NYSE:PSX)
Zacks Research Has Positive View of Phillips 66 Q3 Earnings
Scotiabank Downgrades Phillips 66 (PSX)
Phillips 66: Great Yield, Growth, And An Activist Catalyst
Phillips 66: Great Yield, Growth, And An Activist Catalyst
Barclays Raises Phillips 66 (NYSE:PSX) Price Target to $127.00
Phillips 66 (PSX) Announces Steady Quarterly Dividend
Phillips 66 Announces Quarterly Dividend | PSX Stock News
Phillips 66 Announces Quarterly Dividend

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$156.87 -0.82 (-0.52%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$156.75 -0.12 (-0.08%)
As of 07/11/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Pfizer stock logo

Pfizer NYSE:PFE

$25.65 -0.13 (-0.50%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$25.66 +0.01 (+0.02%)
As of 07/11/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Phillips 66 stock logo

Phillips 66 NYSE:PSX

$131.66 -2.73 (-2.03%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$130.87 -0.79 (-0.60%)
As of 07/11/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Phillips 66 operates as an energy manufacturing and logistics company in the United States, the United Kingdom, Germany, and internationally. It operates through four segments: Midstream, Chemicals, Refining, and Marketing and Specialties (M&S). The Midstream segment transports crude oil and other feedstocks; delivers refined petroleum products to market; provides terminaling and storage services for crude oil and refined petroleum products; transports, stores, fractionates, exports, and markets natural gas liquids; provides other fee-based processing services; and gathers, processes, transports, and markets natural gas. The Chemicals segment produces and markets ethylene and other olefin products; aromatics and styrenics products, such as benzene, cyclohexane, styrene, and polystyrene; and various specialty chemical products, including organosulfur chemicals, solvents, catalysts, and chemicals used in drilling and mining. The Refining segment refines crude oil and other feedstocks into petroleum products, such as gasolines, distillates, aviation, and renewable. The M&S segment purchases for resale and markets refined petroleum products, including gasolines, distillates, and aviation fuels. This segment also manufactures and markets specialty products, such as base oils and lubricants. Phillips 66 was founded in 1875 and is headquartered in Houston, Texas.